OWL Metabolomics
Derio
About OWL Metabolomics
OWL is a biotechnology company with the mission to identify biomarkers and therapeutic targets in the field of high prevalence diseases. The company is focused in the area of human health, with pioneering applications in the international scientific arena, and its goal is to identify, validate, patent and commercialize diagnosis and/or prognosis systems, as well as therapeutic targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: M&A
- Last round: Series Unknown (Jan 2015)
- Website: owlmetabolomics.com
- Phone: +34 94 431 71 40
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/owl-metabolomics-3585192 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.